Biotech firm acquires 48% of AquaBounty
date:Nov 06, 2012
through biotechnology, said Thomas Kasser, Intrexons animal science division president. AquaBountys pioneering work in genetically modified fish is an initial step toward creating a large-scale, efficient and environmentally safe and sustainable global aquaculture market. We look forward to working with the AquaBounty team to improve aquaculture productivity and expand the reach of their molecular medication technology.

In February, AquaBounty announced it was trying to raise an additional USD
3/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/21 12:35